Award notice observed
Latest variant observed by Bidwake on .
Open this official Contracts Finder notice
Record references
- Release reference
cc644418-f584-45db-bf35-771baf03bc48-856590- Published tags
- award
Public procurement
See the published facts, notice history, awards and supplier links in one place. Open the original Contracts Finder notice for the full record.
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323Published facts
cc644418-f584-45db-bf35-771baf03bc48-856590NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
Observed notice trail
Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.
Award notice observed
Latest variant observed by Bidwake on .
Open this official Contracts Finder notice
cc644418-f584-45db-bf35-771baf03bc48-856590Awards and suppliers
Buyer: NHS EnglandSupplier: Abbvie Ltd
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Accord-UK Ltd
End dates, recurrence wording and links are shown as they appear in public notices. They do not create a new opportunity. If no later linked record appears here, that means Bidwake did not find one in the records it has loaded; it does not prove that none exists.
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Alexion Pharmaceuticals
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Amgen Ltd
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Biogen Ltd.
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Celltrion Healthcare United Kingdom Limited
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: CuraTeQ Biologics s.r.o.
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: DR REDDY'S LABORATORIES (UK) LIMITED
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Fresenius Kabi Limited
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: GlaxoSmithKline UK Limited
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Janssen-Cilag Ltd
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Organon Pharmaceuticals UK Ltd
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Orifarm UK
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Pfizer Ltd
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Roche Products Ltd
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Samsung Bioepis UK Ltd
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Sandoz Ltd
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Sobi (Swedish Orphan Biovitrum Ltd)
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Takeda UK Ltd
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: Thornton and Ross Ltd
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1Buyer: NHS EnglandSupplier: ZENTIVA PHARMA UK LIMITED
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1